Risk Management
| << Back |
SARS-CoV-2 Testing
December 7, 2020
Dear OMIC Insureds:
This month’s Bulletin introduces new risk management resources regarding SARS-CoV-2 testing of patients and staff.
If you elect to conduct such testing in your practice, you may find these FAQ documents and consent forms helpful: https://www.omic.com/covid-test-risk-management-recommendations/.
As always, OMIC policyholders are not required to implement risk management recommendations. Rather, physicians should use their professional judgment in determining the applicability of a given recommendation to their particular patients and practice situation.
Many policyholders have inquired if they are covered for offering SARS-CoV-2 testing. A discussion of this and related questions can be found on our website: https://www.omic.com/covid-19-coverage-information/. Questions about coverage should be directed to Underwriting at 1-800-562-6642, ext. 639, or omic@omic.com.
If you have questions about the risk management resources, contact us for confidential risk management advice by emailing us at riskmanagement@omic.com.
Best wishes for a healthy and happy holiday season.
Linda D. Harrison, PhD
Director, OMIC Risk Management
CONFIDENTIALITY NOTICE: This correspondence is intended only for the person or entity to which it is addressed and may contain information that is privileged, confidential or otherwise protected from disclosure. Dissemination, distribution or copying of this e-mail or the information herein by anyone other than the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, is prohibited. If you have received this e-mail in error, please notify us at riskmanagement@omic.com and destroy the original message and all copies.
______________________________________________
As long as we have a current email address for you, you will automatically receive this message. If you do not wish to receive the E-Bulletin, please click the reply button and write REMOVE in the subject line or email omic@omic.com.
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website
